Cholesterol News: Experimental Heart Drug Fails to Slow Atherosclerosis
By Marcia Trahan, March 26, 2007
Three new studies found that torcetrapib, an experimental heart drug, did not inhibit atherosclerosis, or plaque build-up in coronary arteries.
Two studies' results were presented March 26 at the American College of Cardiology's annual meeting in New Orleans. A third study will appear in the March 29 issue of the New England Journal of Medicine.
"Something very strange is going on with this drug [torcetrapib], where none of these fantastic changes translate into benefit for the arterial walls," said Dr. John J.P. Kastelein of the Academic Medical Center in Amsterdam, who led the research team for two of the three studies.
Read the full news story from here @ Associated Content
No comments:
Post a Comment